Shire HGT

Shire Human Genetic Therapies, a subsidiary of Takeda Pharmaceutical Company Limited, is a global biopharmaceutical company based in Cambridge, MA. They are dedicated to advancing science and technology to create better health for people and a brighter future for the world, with a focus on gastrointestinal and inflammatory diseases, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines.

With a diverse portfolio and a commitment to sustainable growth, Shire Human Genetic Therapies strives to transform lives through highly innovative, life-transforming medicines, driven by their inherent curiosity and inspired by patients. They aim to address unmet global health needs and improve the lives of patients with rare and complex chronic diseases through their cutting-edge research and development efforts.

Generated from the website